Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles

Introduction Several prognostic factors of chronic lymphocytic leukemia (CLL) have been identified, such as cytogenetic aberrations and recurrent gene mutations. B-cell receptor (BCR) signaling plays an important role in the tumorigenesis of CLL, and its clinical significance in predicting prognosis is also under study. Methods Therefore, we assessed the already-known prognostic markers, immunoglobulin heavy chain (IGH) gene usage and the associations among these factors in 71 patients diagnosed with CLL in our center from October 2017 to March 2022. Sequencing of IGH gene rearrangements was performed using Sanger sequencing or IGH-based next-generation sequencing, and the results were further analyzed for distinct IGH/IGHD/IGHJ genes and the mutational status of the clonotypic IGHV (IGH variable) gene. Results In summary, by analyzing the distribution of potential prognostic factors in CLL patients, we displayed a landscape of molecular profiles, confirmed the predictive value of recurrent genetic mutations and chromosome aberrations, and found that IGHJ3 was associated with favorable markers (mutated IGHV, trisomy 12), while IGHJ6 tended to correlate with unfavorable factors (unmutated IGHV, del17p). Discussion These results provided an indication for IGH gene sequencing in predicting the prognosis of CLL.

[1]  Chuan-Chao Wang,et al.  Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study , 2022, HemaSphere.

[2]  K. Stamatopoulos,et al.  Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL , 2022, Leukemia.

[3]  J. Byrd,et al.  Anti-CD19 CAR T cells in combination with ibrutinib for the treatment of chronic lymphocytic leukemia , 2022, Blood advances.

[4]  M. Gentile,et al.  Unmutated IGHV1-69 CLL Clone Displays a Distinct Gene Expression Profile by a Comparative qRT-PCR Assay , 2022, Biomedicines.

[5]  P. Ghia,et al.  Are we finally getting personal? Moving towards a personalized approach in chronic lymphocytic leukemia. , 2022, Seminars in cancer biology.

[6]  X. Ke,et al.  Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing , 2021, Frontiers in Genetics.

[7]  J. Choi,et al.  Immunoglobulin Gene Clonality Analysis using Next-Generation Sequencing for Improved Minimal Residual Disease Detection with Significant Prognostic Value in Multiple Myeloma Patients. , 2021, The Journal of molecular diagnostics : JMD.

[8]  Marcos González,et al.  Liquid biopsy: a non‐invasive approach for Hodgkin lymphoma genotyping , 2021, British journal of haematology.

[9]  B. Biderman,et al.  Repertoire of Rearranged Immunoglobulin Heavy Chain Genes in Russian Patients With B-Cell Lymphoproliferative Diseases. , 2021, Clinical lymphoma, myeloma & leukemia.

[10]  T. Shanafelt,et al.  The CLL International Prognostic Index predicts outcomes in monoclonal B-cell lymphocytosis and Rai 0 CLL , 2021, Blood.

[11]  Zhi-Nan Xia,et al.  IGLL5 is correlated with tumor‐infiltrating immune cells in clear cell renal cell carcinoma , 2021, FEBS open bio.

[12]  X. Yao,et al.  The Usage of Human IGHJ Genes Follows a Particular Non-random Selection: The Recombination Signal Sequence May Affect the Usage of Human IGHJ Genes , 2020, Frontiers in Genetics.

[13]  E. Campo,et al.  Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL. , 2020, Blood.

[14]  J. Hernández-Rivas,et al.  Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications , 2020, International journal of cancer.

[15]  J. Byrd,et al.  Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study , 2020, Clinical Cancer Research.

[16]  K. Stamatopoulos,et al.  Tracing CLL-biased stereotyped immunoglobulin gene rearrangements in normal B cell subsets using a high-throughput immunogenetic approach , 2020, Molecular Medicine.

[17]  P. Campregher,et al.  Distinctive IGHV gene usage and stereotyped receptors in South American patients with chronic lymphocytic leukemia , 2019, Hematological oncology.

[18]  J. Bailey,et al.  The whole genome landscape of Burkitt lymphoma subtypes. , 2019, Blood.

[19]  M. Hallek Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment , 2019, American journal of hematology.

[20]  J. Burger,et al.  The importance of B cell receptor isotypes and stereotypes in chronic lymphocytic leukemia , 2018, Leukemia.

[21]  E. Campo,et al.  Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia , 2018, Haematologica.

[22]  J. Byrd,et al.  iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. , 2018, Blood.

[23]  P. A. Futreal,et al.  Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide. , 2018, Blood.

[24]  R. Fulton,et al.  A multiple myeloma-specific capture sequencing platform discovers novel translocations and frequent, risk-associated point mutations in IGLL5 , 2018, Blood Cancer Journal.

[25]  I. Vlahavas,et al.  Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes , 2017, Clinical Cancer Research.

[26]  R. Foà,et al.  Immunoglobulin gene rearrangements in Chinese and Italian patients with chronic lymphocytic leukemia. , 2016, Oncotarget.

[27]  Andrew W. Greaves,et al.  The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience , 2016, British journal of haematology.

[28]  Scott D Boyd,et al.  DJ Pairing during VDJ Recombination Shows Positional Biases That Vary among Individuals with Differing IGHD Locus Immunogenotypes , 2016, The Journal of Immunology.

[29]  M. Kalos,et al.  The Addition of the BTK Inhibitor Ibrutinib to Anti-CD19 Chimeric Antigen Receptor T Cells (CART19) Improves Responses against Mantle Cell Lymphoma , 2016, Clinical Cancer Research.

[30]  S. Gabriel,et al.  Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution , 2015, Nature Communications.

[31]  Lefteris Angelis,et al.  Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study. , 2014, The Lancet. Haematology.

[32]  E. Giné,et al.  Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption , 2014, Haematologica.

[33]  J. Hernández-Rivas,et al.  Mutation Status and Immunoglobulin Gene Rearrangements in Patients from Northwest and Central Region of Spain with Chronic Lymphocytic Leukemia , 2014, BioMed research international.

[34]  Kostas Stamatopoulos,et al.  Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies. , 2012, Blood.

[35]  D. Rossi,et al.  The IGHV1-69/IGHJ3 recombinations of unmutated CLL are distinct from those of normal B cells. , 2012, Blood.

[36]  T. Shanafelt,et al.  Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients. , 2008, The Journal of clinical investigation.

[37]  Nikolaos Laoutaris,et al.  Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. , 2006, Blood.

[38]  D. Catovsky,et al.  The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL. , 1994, Leukemia.